Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Dow Inc. (NYSE: DOW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers DOW
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fly-E Group, Inc. (NASDAQ: FLYE)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fluor Corporation (NYSE: FLR)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLR
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (NASDAQ: LFMD)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LFMD
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against SelectQuote, Inc. (NYSE: SLQT)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SLQT
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Nutex Health Inc. (NASDAQ: NUTX)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers NUTX
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Charter Communications, Inc. (NASDAQ: CHTR)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers CHTR
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Tronox Holdings PLC (NYSE: TROX)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers TROX
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Snap Inc. (NYSE: SNAP)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SNAP
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against KinderCare Learning Companies, Inc. (NYSE: KLC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers KLC
nCino advances AI for mortgage lending with powerful new capabilities
From nCino, Inc.
Via GlobeNewswire
Tickers NCNO
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (NASDAQ: LNTH)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LNTH
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against C3.ai, Inc. (NYSE: AI)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers AI
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against V.F. Corporation (NYSE: VFC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers VFC
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers BIOA
Bombardier’s Global 7500 Jet Soars to New Heights With its 150th Speed Record, Building on its Industry-Defining Record-Setting Performance
From Bombardier Inc.
Via GlobeNewswire
Tickers BDRBF TSX:BBD-A TSX:BBD-B
APPLOVIN (APP) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers APP
KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers KYTX
MATCH GROUP INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Match Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers MTCH
ADM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Archer-Daniels-Midland Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ADM
WELLS FARGO (WFC) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Wells Fargo on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers WFC
Occidental Promotes Richard A. Jackson to Senior Vice President and Chief Operating Officer
From Occidental
Via GlobeNewswire
Tickers OXY
EnviroGold Global Announces Progress to Support U.S. Silver Supply Security with NVRO Process™
From EnviroGold Global Limited
Via GlobeNewswire
Tickers CSE:NVRO ESGLF
Vanqua Bio Highlights Positive Interim Data from its Ongoing Phase 1b Clinical Trial of VQ-101, an Allosteric Activator of GCase for the Treatment of GBA-Parkinson’s and Related Disorders, at The International Congress of Parkinson’s Disease and Movement
From Vanqua Bio
Via GlobeNewswire
KRISPY KREME (DNUT) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Kreme, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers DNUT
OTC Markets Group Welcomes Alaska Silver Corp. to OTCQX
From OTC Markets
Via GlobeNewswire
Tickers OTCM TSX-V:WAM WAMFF
Aduro Clean Technologies to Present at Leading Industry Events in October
From Aduro Clean Technologies Inc.
Via GlobeNewswire
Tickers ACTHF ADUR CSE:ACT
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
Tickers GDTC
AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease
From AAVantgarde
Via GlobeNewswire
Perspective Therapeutics Announces First Patient Dosed with PSV359 in the Second Cohort of a Phase 1/2a Study in Patients with FAP-α Positive Solid Tumors
From Perspective Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.